DK1848446T3 - anvendelse af jern(III)-kompleksforbindelser - Google Patents

anvendelse af jern(III)-kompleksforbindelser

Info

Publication number
DK1848446T3
DK1848446T3 DK06707742.0T DK06707742T DK1848446T3 DK 1848446 T3 DK1848446 T3 DK 1848446T3 DK 06707742 T DK06707742 T DK 06707742T DK 1848446 T3 DK1848446 T3 DK 1848446T3
Authority
DK
Denmark
Prior art keywords
iron
iii
complex compounds
carbohydrates
medicament
Prior art date
Application number
DK06707742.0T
Other languages
English (en)
Inventor
Jessica Tanner-Baumgartner
Ranjeet Chandra
Peter Geisser
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Application granted granted Critical
Publication of DK1848446T3 publication Critical patent/DK1848446T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK06707742.0T 2005-02-09 2006-01-18 anvendelse af jern(III)-kompleksforbindelser DK1848446T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05100907 2005-02-09
PCT/EP2006/050276 WO2006084782A1 (de) 2005-02-09 2006-01-18 Verwendung von eisen(iii)-komplexverbindungen

Publications (1)

Publication Number Publication Date
DK1848446T3 true DK1848446T3 (da) 2010-02-15

Family

ID=34938674

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06707742.0T DK1848446T3 (da) 2005-02-09 2006-01-18 anvendelse af jern(III)-kompleksforbindelser

Country Status (26)

Country Link
US (2) US8722101B2 (da)
EP (1) EP1848446B1 (da)
JP (1) JP5060312B2 (da)
KR (1) KR20070107106A (da)
CN (1) CN101155593A (da)
AT (1) ATE445406T1 (da)
AU (1) AU2006212322B2 (da)
BR (1) BRPI0606974A2 (da)
CA (1) CA2597154C (da)
CR (1) CR9300A (da)
CY (1) CY1109685T1 (da)
DE (1) DE502006005100D1 (da)
DK (1) DK1848446T3 (da)
ES (1) ES2333814T3 (da)
HR (1) HRP20100027T1 (da)
IL (1) IL185020A (da)
MX (1) MX2007009588A (da)
NO (1) NO20074536L (da)
PL (1) PL1848446T3 (da)
PT (1) PT1848446E (da)
RU (1) RU2359680C2 (da)
SI (1) SI1848446T1 (da)
TN (1) TNSN07307A1 (da)
UA (1) UA88347C2 (da)
WO (1) WO2006084782A1 (da)
ZA (1) ZA200707716B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
EP1973549B1 (en) 2006-01-06 2016-07-20 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
EP2165713B1 (en) * 2008-09-19 2012-11-14 Nestec S.A. Whey and thymus function
LT3156075T (lt) 2009-03-25 2021-01-11 Pharmacosmos Holding A/S Oligosacharidas ir jo paruošimo būdas
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
US11395502B2 (en) * 2012-10-18 2022-07-26 Patrick Monsivais Formulation for iron supplements
BR112015024571A2 (pt) * 2013-03-28 2017-07-18 Vifor Int Ag compostos de complexo de ferro(iii), medicamento, e, composição
KR20150078375A (ko) * 2013-12-30 2015-07-08 한화케미칼 주식회사 철산화물 나노입자를 포함하는 철결핍증의 예방 또는 치료용 약학 조성물
FR3075001B1 (fr) * 2017-12-14 2021-09-10 Tereos Starch & Sweeteners Belgium Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau
CN114288320A (zh) * 2021-12-29 2022-04-08 珠海天翼医药技术开发有限公司 一种猪用口服补铁剂及其制备方法
KR20250046064A (ko) 2023-09-26 2025-04-02 주식회사 페라메드 신규한 착화합물, 그를 포함하는 방사선 노출로 인한 조혈 기능 장애 질환의 예방 또는 치료용 약학 조성물 및 그의 제조방법
KR20250110406A (ko) 2024-01-11 2025-07-21 주식회사 페라메드 신규한 착화합물을 이용한 핵산의 증폭 유무를 판별하는 방법
CA3280511A1 (en) 2024-07-18 2026-03-01 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases and iron supplementation in neurodevelopmental or psychiatric disorder

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076798A (en) * 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3766165A (en) 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
DE4421159C1 (de) 1994-06-20 1995-08-24 Thomas Bruns Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
RU2158595C1 (ru) * 1999-07-07 2000-11-10 Латыпова Лилия Фуатовна Способ лечения иммунопатий при железодефицитной анемии у часто болеющих детей, проживающих в крупном промышленном городе с развитой химической и нефтехимической промышленностью
DK1363951T3 (da) * 2000-12-07 2007-03-12 Ad Zdravlje Farmaceutsko Hemij Polynukleært jern(III)kompleks med pullulanoligomerer, fremgangsmåde til dens opnåelse og farmaceutiske præparater på basis af komplekset
EP1377594A4 (en) 2001-04-10 2004-06-30 Danisco Usa Inc POLYMERIZATION OF MONO- AND DISACCHARIDES WITH MONOCARBOXYLIC ACIDS AND LACTONES
RU2208440C2 (ru) * 2001-07-20 2003-07-20 Иркутский институт химии им. А.Е. Фаворского СО РАН Средство, обладающее противоанемической и иммуномодуляторной активностью
EP1492821B1 (en) 2002-04-09 2006-08-02 Pharmacosmos Holding A/S Iron dextrin compounds for the treatment of iron deficiency anaemia
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
CR9300A (es) 2007-12-07
JP2008530049A (ja) 2008-08-07
EP1848446A1 (de) 2007-10-31
BRPI0606974A2 (pt) 2009-07-28
KR20070107106A (ko) 2007-11-06
AU2006212322A1 (en) 2006-08-17
CA2597154A1 (en) 2006-08-17
US8722101B2 (en) 2014-05-13
ATE445406T1 (de) 2009-10-15
CN101155593A (zh) 2008-04-02
RU2359680C2 (ru) 2009-06-27
US20080214496A1 (en) 2008-09-04
RU2007133509A (ru) 2009-03-20
CA2597154C (en) 2011-03-15
PL1848446T3 (pl) 2010-03-31
DE502006005100D1 (de) 2009-11-26
PT1848446E (pt) 2009-12-21
EP1848446B1 (de) 2009-10-14
ES2333814T3 (es) 2010-03-01
IL185020A0 (en) 2007-12-03
WO2006084782A1 (de) 2006-08-17
JP5060312B2 (ja) 2012-10-31
US20140187514A1 (en) 2014-07-03
IL185020A (en) 2013-10-31
AU2006212322B2 (en) 2012-01-19
UA88347C2 (ru) 2009-10-12
CY1109685T1 (el) 2014-08-13
HRP20100027T1 (hr) 2010-02-28
TNSN07307A1 (en) 2008-12-31
ZA200707716B (en) 2008-06-25
NO20074536L (no) 2007-11-05
MX2007009588A (es) 2007-09-12
SI1848446T1 (sl) 2010-01-29

Similar Documents

Publication Publication Date Title
CR9300A (es) Uso de compuestos de hierro (iii)
ES2572329A2 (es) Combinacion de al menos dos agentes antivirales de accion directa y ribavirina pero no interferon, para uso en el tratamientodel vhc
BRPI0813237B8 (pt) composto, método para preparar o composto, medicamento, e, uso do composto
BR112012018345A2 (pt) "compostos de heteroarila, bem como composições e usos dos mesmos"
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
MX355877B (es) Peptidos terapeuticos.
NO20074824L (no) Forlengelse av tid til sykdomsprogresjon eller overlevelse hos kreftpasienter
WO2009026179A3 (en) Antiinfective proanthocyanidin compounds and methods of use thereof
EA200901241A1 (ru) Соединения для лечения гепатита с
UA102858C2 (ru) Производные пиридино-пиридинонов, способ их получения и применения в терапии
EA200870515A1 (ru) Моноциклические гетероарильные соединения
TW200942524A (en) Novel aminomethyl benzene derivatives
EA201070009A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
MA35816B1 (fr) Dérivés d'aniline, leur préparation et leur application thérapeutique
EA201201623A1 (ru) Лечение диабета 2 типа
WO2006124861A3 (en) Benzofuran compounds
EA201000391A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
EA201170605A1 (ru) Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
EA201000392A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
EA201000432A1 (ru) Фунгицидные смеси тритиконазола и дифеноконазола
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
ECSP078024A (es) Inhibidores de la adenilato ciclasa soluble
WO2007121883A3 (de) 1,4:3,6-dianhydromannitol-derivate und deren verwendung